Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
acetylon pharmaceuticals
ambys medicines
artificial intelligence
balderton capital
boston blog main
boston top stories
cell therapy
constellation pharmaceuticals
deals
dna sequencing
europe
fundings & exits
gene therapy
genentech
health
holger willenbring
ibm watson
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
life sciences
liver disease
markus grompe
martin burke
national blog main
national top stories
new york blog main
new york top stories
oregon stem cell center
predictive medicine
proteon therapeutics
salk institute for biological studies
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
software as a service
What
big
2
×
biotech
2
×
diseases
startup
aiming
algorithms
ambys
analytics
balderton
based
better
built
cancer
clinicians
control
data
deadly
deal
debuted
diagnoses
diagnostic
diagnostics
enhance
expertise
faster
formed
future
genetics
genomic
harnesses
healthcare
hoping
ibm
joins
launch
leading
liver
make
medical
medicines
Language
Current search:
big
×
biotech
×
biotech
×
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
6 years ago
Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics
